Bing H. Wang

4.8k total citations · 1 hit paper
119 papers, 3.8k citations indexed

About

Bing H. Wang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Bing H. Wang has authored 119 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 39 papers in Molecular Biology and 19 papers in Surgery. Recurrent topics in Bing H. Wang's work include Cardiac Fibrosis and Remodeling (19 papers), Heart Failure Treatment and Management (15 papers) and Cardiovascular Function and Risk Factors (14 papers). Bing H. Wang is often cited by papers focused on Cardiac Fibrosis and Remodeling (19 papers), Heart Failure Treatment and Management (15 papers) and Cardiovascular Function and Risk Factors (14 papers). Bing H. Wang collaborates with scholars based in Australia, United States and China. Bing H. Wang's co-authors include Andrew R. Kompa, Henry Krum, Darren J. Kelly, Suree Lekawanvijit, Gideon M. Polya, Anastasia Adrahtas, Thomas G. von Lueder, Li Huang, Dan Atar and Danny Liew and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and JAMA.

In The Last Decade

Bing H. Wang

110 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis

2021 235 citations Yuanyuan Wang, Flavia Cicuttini et al. profile →

Peers

Countries citing papers authored by Bing H. Wang

Since Specialization

Citations

This map shows the geographic impact of Bing H. Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing H. Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing H. Wang more than expected).

Fields of papers citing papers by Bing H. Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing H. Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing H. Wang. The network helps show where Bing H. Wang may publish in the future.

Co-authorship network of co-authors of Bing H. Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Bing H. Wang. A scholar is included among the top collaborators of Bing H. Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bing H. Wang. Bing H. Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decreased Endogenous Nitric Oxide Production in Acute Decompensated Heart Failure with a Reduced Ejection Fraction 2025 ·ESC Heart Failure ·(unknown), Bing H. Wang, Sara Vogrin, Christopher Neil	0
2	Structure–Activity Relationships of Highly Potent and Selective A _2B Adenosine Receptor Agonists 2025 ·Journal of Medicinal Chemistry ·Christopher J. Smedley, (unknown), Thi Nguyen, Bing H. Wang, Arthur Christopoulos, Manuela Jörg, Lauren T. May, Peter J. Scammells	0
3	STAREE-HEART: A randomized placebo-controlled trial of atorvastatin effects on a marker of cardiac aging in older individuals without prior cardiovascular disease events: Protocol and baseline description of participants 2025 ·American Heart Journal ·Ingrid Hopper, Thomas H. Marwick, Rory Wolfe, John Amerena, Andrea J. Curtis, (unknown), Daniel J. Green, David M. Kaye, (unknown), John J. McNeil, Mark Nelson, Christopher M. Reid, (unknown), Andrew Tonkin, Bing H. Wang, Zhen Zhou, Sophia Zoungas	0
4	A machine learning approach to predicting vascular calcification risk of type 2 diabetes: A retrospective study 2024 ·Clinical Cardiology ·(unknown), Xinyu Li, Guosheng Li, Bing H. Wang, Yudan Liu, Dongli Sun, Li Liu, Ran Zhang, (unknown), (unknown), (unknown), Zhengnan Gao, (unknown)	1
5	Proteomic and metabolomic profiling of plasma uncovers immune responses in patients with Long COVID-19 2024 ·Frontiers in Microbiology ·Yulin Wei, (unknown), Jun Ma, (unknown), Bing H. Wang, (unknown), (unknown), Jin‐Yuan Wang, Huan Zhao, (unknown)	2
6	Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells 2021 ·The International Journal of Biochemistry & Cell Biology ·Ruth Magaye, Feby Savira, Hua Yue, Xin Xiong, Li Huang, Christopher M. Reid, Bernard L. Flynn, David M. Kaye, Danny Liew, Bing H. Wang	24
7	Sphingolipid imbalance and inflammatory effects induced by uremic toxins in heart and kidney cells are reversed by dihydroceramide desaturase 1 inhibition 2021 ·Toxicology Letters ·Feby Savira, Ruth Magaye, (unknown), Bernard L. Flynn, Stuart M. Pitson, Dovile Anderson, Darren J. Creek, Hua Yue, Xin Xiong, Li Huang, Danny Liew, Christopher M. Reid, David M. Kaye, Andrew R. Kompa, Bing H. Wang	9
8	Insulin-like growth factor-1 directly affects cardiac cellular remodelling via distinct pathways 2021 ·IJC Heart & Vasculature ·(unknown), (unknown), Ping Fu, Henry Krum, Leon A. Bach, Bing H. Wang	4
9	Increased Cardiomyocyte Alignment and Intracellular Calcium Transients Using Micropatterned and Drug-Releasing Poly(Glycerol Sebacate) Elastomers 2018 ·ACS Biomaterials Science & Engineering ·Chenghao Zhu, Andrew E. Rodda, Vinh X. Truong, Yue Shi, Kun Zhou, John M. Haynes, Bing H. Wang, Wayne D. Cook, John S. Forsythe	23
10	Association of expression of ZNF606 gene from monocytes with the risk of coronary artery disease 2018 ·Clinical Biochemistry ·(unknown), (unknown), Yang Liu, Lu Lu, Hua Yue, Rong Hu, Mingqing Wang, Zhiliang Li, Xianbao Wang, Bing H. Wang, Qiang Fu, Aihua Chen	3
11	Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome 2017 ·PLoS ONE ·Feby Savira, Longxing Cao, Ian Wang, Wendi Yang, (unknown), Hua Yue, Beat M. Jucker, Robert N. Willette, Li Huang, Henry Krum, Zhiliang Li, Qiang Fu, Bing H. Wang	29
12	Association between urinary C-telopeptide fragments of type II collagen and knee structure in middle-aged women without clinical knee disease 2014 ·Osteoarthritis and Cartilage ·Bing H. Wang, (unknown), Flavia Cicuttini, Fahad Hanna, Susan R. Davis, Robin J. Bell, Yuanyuan Wang	8
13	FT011, a New Anti-Fibrotic Drug, Attenuates Fibrosis and Chronic Heart Failure in Experimental Diabetic Cardiomyopathy 2012 ·European Journal of Heart Failure ·Yuan Zhang, Amanda J. Edgley, Alison J. Cox, Andrew K. Powell, Bing H. Wang, Andrew R. Kompa, David Stapleton, Steven C. Zammit, Spencer J. Williams, Henry Krum, Richard E. Gilbert, Darren J. Kelly	41
14	Abstract 11507: Subtotal Nephrectomy Accelerates Pathological Cardiac Remodelling Post Myocardial Infarction: Recapitulating the Phenotype of Cardiorenal Syndrome? 2011 ·Circulation ·Shan Liu, Andrew R. Kompa, Darren J. Kelly, Henry Krum, Bing H. Wang	1
15	Abstract 12344: Apoptosis Signal-Regulating Kinase 1 Inhibition Attenuates Cardiac Myocyte Hypertrophy and Fibroblast Collagen Synthesis Stimulated by Angiotensin II- and TGFβ: Therapeutic Potential of ASK1 Inhibitors in Myocardial Remodelling 2011 ·Circulation ·Bing H. Wang, (unknown), (unknown), Andrew R. Kompa, Beat M. Jucker, Robert N. Willette, Henry Krum	2
16	Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? 2010 ·European Heart Journal ·Suree Lekawanvijit, Anastasia Adrahtas, Darren J. Kelly, Andrew R. Kompa, Bing H. Wang, (unknown)	255
17	Abstract 1500: Does Indoxyl Sulfate, A Uremic Toxin, Have Direct Effects on Cardiac Fibroblasts & Myocytes? 2008 ·Circulation ·Suree Lekawanvijit, Anastasia Adrahtas, Darren J. Kelly, Henry Krum, Bing H. Wang	1
18	Monitoring of Isotope Substitution in Cyanobacteria by Matrix-Assisted Laser Desorption Ionization–Time-of-Flight Mass Spectrometry 2000 ·Analytical Biochemistry ·Marina Belenky, Bing H. Wang, Alexei Belenky, Judith Herzfeld	2
19	Inhibition of Eukaryote Protein Kinases by Isoquinoline and Oxazine Alkaloids 1997 ·Planta Medica ·Bing H. Wang, Zhe Lü, Gideon M. Polya	47
20	The Fungal Teratogen Secalonic Acid D is an Inhibitor of Protein Kinase C and of Cyclic AMP-Dependent Protein Kinase 1996 ·Planta Medica ·Bing H. Wang, Gideon M. Polya	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact